Chinook Therapeutics, Inc.

Candriam S.C.A.

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/8/2023

Shares

826,155

Value ($000)

31,741

Weight

0.2%

2021 Q2 - 2023 Q2 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/8/2023	31,741	0.2%	826,155	6/30/2023
2023 Q1	5/12/2023	19,734	0.1%	926,155	3/31/2023
2022 Q4	2/13/2023	24,264	0.2%	926,155	12/31/2022
2022 Q3	11/10/2022	17,128	0.1%	871,155	9/30/2022
2022 Q2	8/3/2022	15,236	0.1%	871,155	6/30/2022
2022 Q1	5/13/2022	19,391	0.1%	1,185,314	3/31/2022
2021 Q4	2/10/2022	18,021	0.1%	1,104,902	12/31/2021
2021 Q3	11/9/2021	11,516	0.1%	902,537	9/30/2021
2021 Q2	7/20/2021	12,357	0.1%	875,124	6/30/2021